Pathogenesis of arenavirus hemorrhagic fevers

References

• Geisbert TW, Jahrling PB. Exotic emerging viral diseases: progress and challenges. Nat. Med.10(12 Suppl.), S110–S121 (2004).
   PubMed Web of Science ®Google Scholar
• Buchmeier MJ, de la Torre JC, Peters CJ. Arenaviridae: the viruses and their replication. In: Fields Virology. Knipe DL, Howley PM (Eds.) Lippincott-Raven, Philadelphia, PA, USA, 1791–1828 (2007).
   Google Scholar
• McCormick JB, Fisher-Hoch SP. Lassa fever. Curr. Top. Microbiol. Immunol.262, 75–109 (2002).
   PubMed Web of Science ®Google Scholar
• Barton LL, Mets MB, Beauchamp CL. Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am. J. Obstet. Gynecol.187(6), 1715–1716 (2002).
   PubMed Web of Science ®Google Scholar
• Jamieson DJ, Kourtis AP, Bell M, Rasmussen SA. Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am. J. Obstet. Gynecol.194(6), 1532–1536 (2006).
   PubMed Web of Science ®Google Scholar
• Fischer SA, Graham MB, Kuehnert MJ et al. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med.354(21), 2235–2249 (2006).
   PubMed Web of Science ®Google Scholar
• Palacios G, Druce J, Du L et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N. Engl. J. Med.358(10), 991–998 (2008).
   PubMed Web of Science ®Google Scholar
• Borio L, Inglesby T, Peters CJ et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA287(18), 2391–2405 (2002).
   PubMed Web of Science ®Google Scholar
• Emonet SF, de la Torre JC, Domingo E, Sevilla N. Arenavirus genetic diversity and its biological implications. Infect. Genet. Evol.9(4), 417–429 (2009).
   PubMed Web of Science ®Google Scholar
• Charrel RN, de Lamballerie X, Emonet S. Phylogeny of the genus Arenavirus. Curr. Opin. Microbiol.11(4), 362–368 (2008).
   PubMed Web of Science ®Google Scholar
• (CDC) CfDCaP. Fatal illnesses associated with a new world arenavirus – California, 1999–2000. MMWR Morb. Mortal. Wkly Rep.49(31), 709–711 (2000).
   PubMedGoogle Scholar
• Enserink M. Emerging diseases. New arenavirus blamed for recent deaths in California. Science289(5481), 842–843 (2000).
   PubMed Web of Science ®Google Scholar
• Charrel RN, Lemasson JJ, Garbutt M et al. New insights into the evolutionary relationships between arenaviruses provided by comparative analysis of small and large segment sequences. Virology317(2), 191–196 (2003).
   PubMed Web of Science ®Google Scholar
• Delgado S, Erickson BR, Agudo R et al. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog.4(4), e1000047 (2008).
   PubMed Web of Science ®Google Scholar
• Briese T, Paweska JT, McMullan LK et al. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog.5(5), e1000455 (2009).
   PubMed Web of Science ®Google Scholar
• Weissenbacher MC, Laguens RP, Coto CE. Argentine hemorrhagic fever. Curr. Top. Microbiol. Immunol.134, 79–116 (1987).
   PubMedGoogle Scholar
• de la Torre JC. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses. Ann. NY Acad. Sci.1171(Suppl. 1), E57–E64 (2009).
   Google Scholar
• Lenz O, ter Meulen J, Klenk HD, Seidah NG, Garten W. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc. Natl Acad. Sci. USA98(22), 12701–12705 (2001).
   PubMed Web of Science ®Google Scholar
• Beyer WR, Popplau D, Garten W, von Laer D, Lenz O. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J. Virol.77(5), 2866–2872 (2003).
   PubMed Web of Science ®Google Scholar
• Rojek JM, Lee AM, Nguyen N, Spiropoulou CF, Kunz S. Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin, Machupo, and Guanarito. J. Virol.82(12), 6045–6051 (2008).
   PubMed Web of Science ®Google Scholar
• Cao W, Henry MD, Borrow P et al. Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus [see comments]. Science282(5396), 2079–2081 (1998).
   PubMed Web of Science ®Google Scholar
• Kunz S. Receptor binding and cell entry of Old World arenaviruses reveal novel aspects of virus–host interaction. Virology387(2), 245–249 (2009).
   PubMed Web of Science ®Google Scholar
• Radoshitzky SR, Abraham J, Spiropoulou CF et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature446(7131), 92–96 (2007).
   PubMed Web of Science ®Google Scholar
• Borrow P, Oldstone MB. Mechanism of lymphocytic choriomeningitis virus entry into cells. Virology198(1), 1–9 (1994).
   PubMed Web of Science ®Google Scholar
• Martinez MG, Cordo SM, Candurra NA. Characterization of Junin arenavirus cell entry. J. Gen. Virol.88(Pt 6), 1776–1784 (2007).
   PubMed Web of Science ®Google Scholar
• Quirin K, Eschli B, Scheu I, Poort L, Kartenbeck J, Helenius A. Lymphocytic choriomeningitis virus uses a novel endocytic pathway for infectious entry via late endosomes. Virology378(1), 21–33 (2008).
   PubMed Web of Science ®Google Scholar
• Rojek JM, Perez M, Kunz S. Cellular entry of lymphocytic choriomeningitis virus. J. Virol.82(3), 1505–1517 (2008).
   PubMed Web of Science ®Google Scholar
• Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J. Virol.82(15), 7677–7687 (2008).
   PubMed Web of Science ®Google Scholar
• Perez M, Craven RC, de la Torre JC. The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc. Natl Acad. Sci. USA100(22), 12978–12983 (2003).
   PubMed Web of Science ®Google Scholar
• Strecker T, Eichler R, Meulen J et al. Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J. Virol.77(19), 10700–10705 (2003).
   PubMed Web of Science ®Google Scholar
• Frame JD, Baldwin JM Jr, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am. J. Trop. Med. Hyg.19(4), 670–676 (1970).
   PubMed Web of Science ®Google Scholar
• Buckley SM, Casals J. Lassa fever, a new virus disease of man from West Africa. 3. Isolation and characterization of the virus. Am. J. Trop. Med. Hyg.19(4), 680–691 (1970).
   PubMed Web of Science ®Google Scholar
• Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science185(147), 263–265 (1974).
   PubMed Web of Science ®Google Scholar
• Safronetz D, Lopez JE, Sogoba N et al. Detection of Lassa virus, Mali. Emerg. Infect. Dis.16(7), 1123–1126 (2010).
   PubMed Web of Science ®Google Scholar
• Richmond JK, Baglole DJ. Lassa fever: epidemiology, clinical features, and social consequences. Br. Med. J.327(7426), 1271–1275 (2003).
   PubMed Web of Science ®Google Scholar
• McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis.155(3), 437–444 (1987).
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch SP, Tomori O, Nasidi A et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Br. Med. J.311(7009), 857–859 (1995).
   PubMed Web of Science ®Google Scholar
• McCormick JB, King IJ, Webb PA et al. A case–control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis.155(3), 445–455 (1987).
   PubMed Web of Science ®Google Scholar
• Price ME, Fisher-Hoch SP, Craven RB, McCormick JB. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Br. Med. J.297(6648), 584–587 (1988).
   PubMed Web of Science ®Google Scholar
• Cummins D, McCormick JB, Bennett D et al. Acute sensorineural deafness in Lassa fever. JAMA264(16), 2093–2096 (1990).
   PubMed Web of Science ®Google Scholar
• Johnson KM, McCormick JB, Webb PA, Smith ES, Elliott LH, King IJ. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis.155(3), 456–464 (1987).
   PubMed Web of Science ®Google Scholar
• Walker DH, McCormick JB, Johnson KM et al. Pathologic and virologic study of fatal Lassa fever in man. Am. J. Pathol.107(3), 349–356 (1982).
   PubMed Web of Science ®Google Scholar
• McCormick JB, Walker DH, King IJ et al. Lassa virus hepatitis: a study of fatal Lassa fever in humans. Am. J. Trop. Med. Hyg.35(2), 401–407 (1986).
   PubMed Web of Science ®Google Scholar
• Habjan M, Andersson I, Klingstrom J et al. Processing of genome 5’ termini as a strategy of negative-strand RNA viruses to avoid RIG-I-dependent interferon induction. PLoS One3(4), e2032 (2008).
   PubMed Web of Science ®Google Scholar
• Zhou S, Cerny AM, Zacharia A, Fitzgerald KA, Kurt-Jones EA, Finberg RW. Induction and inhibition of the type I interferon responses by distinct components of lymphocytic choriomeningitis virus. J. Virol.84(18), 9452–9462 (2010).
   PubMed Web of Science ®Google Scholar
• Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol.80(18), 9192–9199 (2006).
   PubMed Web of Science ®Google Scholar
• Martinez-Sobrido L, Emonet S, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC. Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J. Virol.83(21), 11330–11340 (2009).
   PubMed Web of Science ®Google Scholar
• Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC. Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J. Virol.81(22), 12696–12703 (2007).
   PubMed Web of Science ®Google Scholar
• Fan L, Briese T, Lipkin WI. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J. Virol.84(4), 1785–1791 (2010).
   PubMed Web of Science ®Google Scholar
• Baize S, Marianneau P, Loth P et al. Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J. Virol.83(11), 5890–5903 (2009).
   PubMed Web of Science ®Google Scholar
• Fisher SP, Hutwagner L, Brown B, McCormick JB. Effective vaccine for lassa fever. J. Virol.74(15), 6777–6783 (2000).
   PubMed Web of Science ®Google Scholar
• ter Meulen J, Badusche M, Kuhnt K et al. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein. J. Virol.74(5), 2186–2192 (2000).
   PubMed Web of Science ®Google Scholar
• Baize S, Kaplon J, Faure C, Pannetier D, Georges-Courbot MC, Deubel V. Lassa virus infection of human dendritic cells and macrophages is productive but fails to activate cells. J. Immunol.172(5), 2861–2869 (2004).
   PubMed Web of Science ®Google Scholar
• Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, Pulendran B. Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J. Immunol.170(6), 2797–2801 (2003).
   PubMed Web of Science ®Google Scholar
• Mahanty S, Bausch DG, Thomas RL et al. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J. Infect. Dis.183(12), 1713–1721 (2001).
   PubMed Web of Science ®Google Scholar
• Reignier T, Oldenburg J, Noble B et al. Receptor use by pathogenic arenaviruses. Virology353(1), 111–120 (2006).
   PubMed Web of Science ®Google Scholar
• Rojek JM, Spiropoulou CF, Campbell KP, Kunz S. Old World and Clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by α-dystroglycan’s host-derived ligands. J. Virol.81(11), 5685–5695 (2007).
   PubMed Web of Science ®Google Scholar
• McNally JM, Zarozinski CC, Lin MY, Brehm MA, Chen HD, Welsh RM. Attrition of bystander CD8 T cells during virus-induced T-cell and interferon responses. J. Virol.75(13), 5965–5976 (2001).
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch S, McCormick JB, Sasso D, Craven RB. Hematologic dysfunction in Lassa fever. J. Med. Virol.26(2), 127–135 (1988).
   PubMed Web of Science ®Google Scholar
• Cummins D, Fisher-Hoch SP, Walshe KJ et al. A plasma inhibitor of platelet aggregation in patients with Lassa fever. Br. J. Haematol.72(4), 543–548 (1989).
   PubMed Web of Science ®Google Scholar
• Fisher-Hoch SP, Mitchell SW, Sasso DR, Lange JV, Ramsey R, McCormick JB. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J. Infect. Dis.155(3), 465–474 (1987).
   PubMed Web of Science ®Google Scholar
• Aleksandrowicz P, Wolf K, Falzarano D, Feldmann H, Seebach J, Schnittler H. Viral haemorrhagic fever and vascular alterations. Hamostaseologie28(1–2), 77–84 (2008).
   PubMed Web of Science ®Google Scholar
• Schnittler HJ, Feldmann H. Viral hemorrhagic fever – a vascular disease? Thromb. Haemost.89(6), 967–972 (2003).
   PubMed Web of Science ®Google Scholar
• Lukashevich IS, Maryankova R, Vladyko AS et al. Lassa and Mopeia virus replication in human monocytes/macrophages and in endothelial cells: different effects on IL-8 and TNF-α gene expression. J. Med. Virol.59(4), 552–560 (1999).
   PubMed Web of Science ®Google Scholar
• Arribalzaga RA. New epidemic disease due to unidentified germ: nephrotoxic, leukopenic and enanthematous hyperthermia. Dia. Med.27(40), 1204–1210 (1955).
   PubMedGoogle Scholar
• Parodi AS, Greenway DJ, Rugiero HR et al. Concerning the epidemic outbreak in Junin. Dia. Med.30(62), 2300–2301 (1958).
   PubMedGoogle Scholar
• Peters CJ. Human infection with arenaviruses in the Americas. Curr. Top. Microbiol. Immunol.262, 65–74 (2002).
   PubMed Web of Science ®Google Scholar
• Harrison LH, Halsey NA, McKee KT Jr et al. Clinical case definitions for argentine hemorrhagic fever. Clin. Infect. Dis.28(5), 1091–1094 (1999).
   PubMed Web of Science ®Google Scholar
• Kenyon RH, McKee KT Jr, Zack PM et al. Aerosol infection of rhesus macaques with Junin virus. Intervirology33(1), 23–31 (1992).
   PubMed Web of Science ®Google Scholar
• de Bracco MM, Rimoldi MT, Cossio PM et al. Argentine hemorrhagic fever. Alterations of the complement system and anti-Junin-virus humoral response. N. Engl. J. Med.299(5), 216–221 (1978).
   PubMed Web of Science ®Google Scholar
• Ambrosio AM, Enria DA, Maiztegui JI. Junin virus isolation from lympho-mononuclear cells of patients with Argentine hemorrhagic fever. Intervirology25(2), 97–102 (1986).
   PubMed Web of Science ®Google Scholar
• Gonzalez PH, Cossio PM, Arana R, Maiztegui JI, Laguens RP. Lymphatic tissue in Argentine hemorrhagic fever. Pathologic features. Arch. Pathol. Lab. Med.104(5), 250–254 (1980).
   PubMed Web of Science ®Google Scholar
• Levis SC, Saavedra MC, Ceccoli C et al. Correlation between endogenous interferon and the clinical evolution of patients with Argentine hemorrhagic fever. J. Interferon Res.5(3), 383–389 (1985).
   PubMedGoogle Scholar
• Heller MV, Saavedra MC, Falcoff R, Maiztegui JI, Molinas FC. Increased tumor necrosis factor-α levels in Argentine hemorrhagic fever. J. Infect. Dis.166(5), 1203–1204 (1992).
   PubMed Web of Science ®Google Scholar
• Marta RF, Montero VS, Hack CE, Sturk A, Maiztegui JI, Molinas FC. Proinflammatory cytokines and elastase-α-1-antitrypsin in Argentine hemorrhagic fever. Am. J. Trop. Med. Hyg.60(1), 85–89 (1999).
   PubMed Web of Science ®Google Scholar
• Gomez RM, Pozner RG, Lazzari MA et al. Endothelial cell function alteration after Junin virus infection. Thromb. Haemost.90(2), 326–333 (2003).
   PubMed Web of Science ®Google Scholar
• Molinas FC, de Bracco MM, Maiztegui JI. Hemostasis and the complement system in Argentine hemorrhagic fever. Rev. Infect. Dis.11(Suppl. 4), S762–S770 (1989).
   Google Scholar
• Heller MV, Marta RF, Sturk A et al. Early markers of blood coagulation and fibrinolysis activation in Argentine hemorrhagic fever. Thromb. Haemost.73(3), 368–373 (1995).
   PubMed Web of Science ®Google Scholar
• Pozner RG, Ure AE, Jaquenod de Giusti C et al. Junin virus infection of human hematopoietic progenitors impairs in vitro proplatelet formation and platelet release via a bystander effect involving type I IFN signaling. PLoS Pathog.6(4), e1000847 (2010).
   Google Scholar
• Johnson KM, Kuns ML, Mackenzie RB, Webb PA, Yunker CE. Isolation of Machupo virus from wild rodent Calomys callosus. Am. J. Trop. Med. Hyg.15(1), 103–106 (1966).
   PubMed Web of Science ®Google Scholar
• Kilgore PE, Peters CJ, Mills JN et al. Prospects for the control of Bolivian hemorrhagic fever. Emerg. Infect. Dis.1(3), 97–100 (1995).
   PubMed Web of Science ®Google Scholar
• Salas R, de Manzione N, Tesh RB et al. Venezuelan haemorrhagic fever. Lancet338(8774), 1033–1036 (1991).
   PubMed Web of Science ®Google Scholar
• Tesh RB, Jahrling PB, Salas R, Shope RE. Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am. J. Trop. Med. Hyg.50(4), 452–459 (1994).
   PubMed Web of Science ®Google Scholar
• Stinebaugh BJ, Schloeder FX, Johnson KM, Mackenzie RB, Entwisle G, De Alba E. Bolivian hemorrhagic fever. A report of four cases. Am. J. Med.40(2), 217–230 (1966).
   PubMed Web of Science ®Google Scholar
• Johnson KM, Halstead SB, Cohen SN. Hemorrhagic fevers of Southeast Asia and South America: a comparative appraisal. Prog. Med. Virol.9, 105–158 (1967).
   PubMedGoogle Scholar
• de Manzione N, Salas RA, Paredes H et al. Venezuelan hemorrhagic fever: clinical and epidemiological studies of 165 cases. Clin. Infect. Dis.26(2), 308–313 (1998).
   PubMed Web of Science ®Google Scholar
• Enria DA, Barrera Oro JG. Junin virus vaccines. Curr. Top. Microbiol. Immunol.263, 239–261 (2002).
   PubMed Web of Science ®Google Scholar
• Enria DA, Briggiler AM, Sanchez Z. Treatment of Argentine hemorrhagic fever. Antiviral Res.78(1), 132–139 (2008).
   PubMed Web of Science ®Google Scholar
• Callis RT, Jahrling PB, DePaoli A. Pathology of Lassa virus infection in the rhesus monkey. Am. J. Trop. Med. Hyg.31(5), 1038–1045 (1982).
   PubMed Web of Science ®Google Scholar
• Geisbert TW, Jones S, Fritz EA et al. Development of a new vaccine for the prevention of Lassa fever. PLoS Med.2(6), e183 (2005).
   PubMed Web of Science ®Google Scholar
• Jahrling PB, Hesse RA, Eddy GA, Johnson KM, Callis RT, Stephen EL. Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. J. Infect. Dis.141(5), 580–589 (1980).
   PubMed Web of Science ®Google Scholar
• Jahrling PB, Peters CJ. Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. Infect. Immun.44(2), 528–533 (1984).
   PubMed Web of Science ®Google Scholar
• Jahrling PB, Peters CJ, Stephen EL. Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. J. Infect. Dis.149(3), 420–427 (1984).
   PubMed Web of Science ®Google Scholar
• Walker DH, Johnson KM, Lange JV, Gardner JJ, Kiley MP, McCormick JB. Experimental infection of rhesus monkeys with Lassa virus and a closely related arenavirus, Mozambique virus. J. Infect. Dis.146(3), 360–368 (1982).
   PubMed Web of Science ®Google Scholar
• Carrion R Jr, Brasky K, Mansfield K et al. Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues. J. Virol.81(12), 6482–6490 (2007).
   PubMed Web of Science ®Google Scholar
• Lukashevich IS, Djavani M, Rodas JD et al. Hemorrhagic fever occurs after intravenous, but not after intragastric, inoculation of rhesus macaques with lymphocytic choriomeningitis virus. J. Med. Virol.67(2), 171–186 (2002).
   PubMed Web of Science ®Google Scholar
• Lukashevich IS, Tikhonov I, Rodas JD et al. Arenavirus-mediated liver pathology: acute lymphocytic choriomeningitis virus infection of rhesus macaques is characterized by high-level interleukin-6 expression and hepatocyte proliferation. J. Virol.77(3), 1727–1737 (2003).
   PubMed Web of Science ®Google Scholar
• Djavani MM, Crasta OR, Zapata JC et al. Early blood profiles of virus infection in a monkey model for Lassa fever. J. Virol.81(15), 7960–7973 (2007).
   PubMed Web of Science ®Google Scholar
• Djavani M, Crasta OR, Zhang Y et al. Gene expression in primate liver during viral hemorrhagic fever. Virol. J.6, 20 (2009).
   PubMed Web of Science ®Google Scholar
• Flatz L, Rieger T, Merkler D et al. T cell-dependence of Lassa fever pathogenesis. PLoS Pathog.6(3), e1000836 (2010).
   PubMed Web of Science ®Google Scholar
• Liang Y, Lan S, Ly H. Molecular determinants of Pichinde virus infection of guinea pigs – a small animal model system for arenaviral hemorrhagic fevers. Ann. NY Acad. Sci.1171(Suppl. 1), E65–E74 (2009).
   PubMedGoogle Scholar
• Xiao SY, Zhang H, Yang Y, Tesh RB. Pirital virus (Arenaviridae) infection in the syrian golden hamster, Mesocricetus auratus: a new animal model for arenaviral hemorrhagic fever. Am. J. Trop. Med. Hyg.64(3–4), 111–118 (2001).
   PubMed Web of Science ®Google Scholar
• Sbrana E, Mateo RI, Xiao SY, Popov VL, Newman PC, Tesh RB. Clinical laboratory, virologic, and pathologic changes in hamsters experimentally infected with Pirital virus (Arenaviridae): a rodent model of Lassa fever. Am. J. Trop. Med. Hyg.74(6), 1096–1102 (2006).
   PubMed Web of Science ®Google Scholar
• Weissenbacher MC, de Guerrero LB, Boxaca MC. Experimental biology and pathogenesis of Junin virus infection in animals and man. Bull. World Health Organ.52(4–6), 507–515 (1975).
   PubMed Web of Science ®Google Scholar
• Barrios HA, Rondinone SN, Blejer JL, Giovanniello OA, Nota NR. Development of specific immune response in mice infected with Junin virus. Acta. Virol.26(3), 156–164 (1982).
   PubMed Web of Science ®Google Scholar
• Weissenbacher MC, Calello MA, Quintans CJ, Panisse H, Woyskowsky NM, Zannoli VH. Junin virus infection in genetically athymic mice. Intervirology19(1), 1–5 (1983).
   PubMed Web of Science ®Google Scholar
• Campetella OE, Galassi NV, Sanjuan N, Barrios HA. Susceptible adult murine model for Junin virus. J. Med. Virol.26(4), 443–451 (1988).
   PubMed Web of Science ®Google Scholar
• Scolaro LA, Mersich SE, Damonte EB. Experimental infection of suckling mice with a host range mutant of Junin virus. J. Med. Virol.34(4), 237–240 (1991).
   PubMed Web of Science ®Google Scholar
• Kenyon RH, Green DE, Maiztegui JI, Peters CJ. Viral strain dependent differences in experimental Argentine hemorrhagic fever (Junin virus) infection of guinea pigs. Intervirology29(3), 133–143 (1988).
   PubMed Web of Science ®Google Scholar
• Kenyon RH, Green DE, Eddy GA, Peters CJ. Treatment of junin virus-infected guinea pigs with immune serum: development of late neurological disease. J. Med. Virol.20(3), 207–218 (1986).
   PubMed Web of Science ®Google Scholar
• Remesar MC, Blejer JL, Lerman GD, Dejean C, Nejamkis MR. Protection against encephalitis in rats caused by a pathogenic strain of the Junin virus, using peripheral inoculation of an attenuated strain. Rev. Argent. Microbiol.21(3–4), 120–126 (1989).
   PubMedGoogle Scholar
• Weissenbacher MC, Calello MA, Colillas OJ, Rondinone SN, Frigerio MJ. Argentine hemorrhagic fever: a primate model. Intervirology11(6), 363–365 (1979).
   PubMed Web of Science ®Google Scholar
• McKee KT Jr, Mahlandt BG, Maiztegui JI, Eddy GA, Peters CJ. Experimental Argentine hemorrhagic fever in rhesus macaques: viral strain-dependent clinical response. J. Infect. Dis.152(1), 218–221 (1985).
   PubMed Web of Science ®Google Scholar
• McKee KT Jr, Green DE, Mahlandt BG et al. Infection of Cebus monkeys with Junin virus. Medicina (B Aires)45(2), 144–152 (1985).
   PubMed Web of Science ®Google Scholar
• Avila MM, Samoilovich SR, Laguens RP, Merani MS, Weissenbacher MC. Protection of Junin virus-infected marmosets by passive administration of immune serum: association with late neurologic signs. J. Med. Virol.21(1), 67–74 (1987).
   PubMed Web of Science ®Google Scholar
• Carballal G, Oubina JR, Molinas FC et al. Intracerebral infection of Cebus apella with the XJ-Clone 3 strain of Junin virus. J. Med. Virol.21(3), 257–268 (1987).
   PubMed Web of Science ®Google Scholar
• Yun NE, Linde NS, Dziuba N et al. Pathogenesis of XJ and Romero strains of Junin virus in two strains of guinea pigs. Am. J. Trop. Med. Hyg.79(2), 275–282 (2008).
   PubMed Web of Science ®Google Scholar
• Sanchez AB, de la Torre JC. Rescue of the prototypic arenavirus LCMV entirely from plasmid. Virology350(2), 370–380 (2006).
   PubMed Web of Science ®Google Scholar
• Flatz L, Bergthaler A, de la Torre JC, Pinschewer DD. Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc. Natl Acad. Sci. USA103(12), 4663–4668 (2006).
   PubMed Web of Science ®Google Scholar
• Albarino CG, Bergeron E, Erickson BR, Khristova ML, Rollin PE, Nichol ST. Efficient reverse genetics generation of infectious Junin viruses differing in glycoprotein processing. J. Virol.83(11), 5606–5614 (2009).
   PubMed Web of Science ®Google Scholar